DFW Capital Partners Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, DFW Capital Partners has acquired 1 company. It has also invested in 7 others.

DFW Capital Partners’ most common sectors for investment are healthcare services (20%) and life science (20%). The Firm’s most common investment types include growth capital (47%) and buyout (lbo, mbo, mbi) (27%). In total, DFW Capital Partners has invested in 16 US states. Its largest (disclosed) acquisition occurred in 1999 when it acquired Sheridan Healthcare for $155M.

In the last 3 years, DFW Capital Partners has exited 5 companies. The Firm’s most common exit type is trade sale (48%). DFW Capital Partners’ largest (disclosed) exit occurred in 2014 when it sold Vidara Therapeutics for $660M.

Join Mergr to view DFW Capital Partners’ full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity51
    • M&A Buy Activity30
    • M&A Sell Activity21
  • Total Sectors Invested 14
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 24

DFW Capital Partners

300 Frank W. Burr Blvd., Glenpointe Centre East, 5th Floor,
Teaneck, New Jersey 07666
United States
(201) 836-6000
www.dfwcapital.com
info@dfwcapital.com

DFW Capital Partners, Inc. is a private equity firm that invests in high-growth middle-market service companies generating revenues of $20-$150 million with an EBITDA of $3-$15 million. Specific service areas of interest include business services, industrial services, and healthcare services. DFW looks to invest $5 to $20 million per transaction. Prospective transactions include growth capital financing, acquisition financing, management buyouts, and recapitalization. DFW will not invest in start-ups, real estate, or pure R&D companies. DFW Capital Partner, Inc. was formed in 1983 and has offices in Teaneck and Chevy Chase.


Investment Criteria

Sectors of Interest: Business Services, Environmental, Healthcare Services, Information Technology, Insurance, Internet Software and Services, Life Science, Medical Products, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Growth Capital, Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 20 150
Target EBITDA 3 15
Investment Size 5 20
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (2.4/yr) # 18 2 2 4 3 1 30
vol $155M $155M
Sell (1.2/yr) # 15 - 3 2 1 - 21
vol $1.4B $1.4B
  51

Most Recent M&A

Company Date Value Type
WorldCare Clinical LLC 2020-01-06 - Growth Capital
Boston, Massachusetts · www.wcclinical.com
Regulatory and Quality Solutions LLC (R&Q) 2019-10-11 - Growth Capital
Monroeville, Pennsylvania · www.rqteam.com
Vertex Business Services 2019-07-23 - Secondary Buyout
Richardson, Texas · www.vertexone.net
Superior Controls, Inc. 2019-04-17 - Add-on Acquisition
Seabrook, New Hampshire · www.superiorcontrols.com
Sev1Tech, Inc. 2019-03-14 - Growth Capital
Woodbridge, Virginia · www.sev1tech.com
Lotus Clinical Research LLC 2018-11-15 - Growth Capital
Pasadena, California · www.lotuscr.com
FLEETWASH, Inc. 2018-10-02 - Secondary Buyout
Fairfield, New Jersey · www.fleetwash.com
AQUALIS 2018-06-29 - Growth Capital
Durham, North Carolina · www.aqualisco.com
Evolution Research Group LLC 2018-05-30 - Secondary Buyout
Watchung, New Jersey · www.evolutionresearchgroup.com
ReSource Pro 2018-04-17 - Growth Capital
New York, New York · www.resourcepro.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Vertex Business Services 2019-07-23 WaterSmart Software, Inc. 2020-05-06 1
Richardson, Texas · www.vertexone.net San Francisco, California · www.watersmart.com
Saol Therapeutics 2017-01-02 Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products 2017-08-31 1
Roswell, Georgia · www.saolrx.com Seattle, Washington
Envocore 2017-06-30 LRI Energy Solutions LLC 2017-06-30 1
Gambrills, Maryland · www.envocore.com Gambrills, Maryland · www.lrienergysolutions.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 1 (8%) - 6 (20%) 155M (100%)
Life Science 4 (33%) - 6 (20%) -
Information Technology 3 (25%) - 5 (17%) -
Business Services 1 (8%) - 3 (10%) -
Consumer Services - - 1 (3%) -
Defense - - 1 (3%) -
Electronics - - 1 (3%) -
Energy Services and Equipment 1 (8%) - 1 (3%) -
Engineering - - 1 (3%) -
Environmental 1 (8%) - 1 (3%) -
Insurance 1 (8%) - 1 (3%) -
Renewable Energy - - 1 (3%) -
Safety/Security - - 1 (3%) -
Software - - 1 (3%) -
Total 12 - 30 $155M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 12 (100%) - 30 (100%) 155M (100%)
  Pennsylvania 2 (17%) - 5 (17%) -
  Georgia 2 (17%) - 4 (13%) -
  New Jersey - - 3 (10%) -
  Virginia 1 (8%) - 2 (7%) -
  New York 1 (8%) - 2 (7%) -
  Maryland 1 (8%) - 2 (7%) -
  California 1 (8%) - 2 (7%) -
  Florida - - 2 (7%) 155M (100%)
  Texas 1 (8%) - 1 (3%) -
  Ohio 1 (8%) - 1 (3%) -
  North Carolina 1 (8%) - 1 (3%) -
  Massachusetts 1 (8%) - 1 (3%) -
  Vermont - - 1 (3%) -
  Tennessee - - 1 (3%) -
  New Hampshire - - 1 (3%) -
  Michigan - - 1 (3%) -
Total 12 - 30 $155M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 9 (75%) - 14 (47%) -
Buyout (LBO, MBO, MBI) 2 (17%) - 8 (27%) -
Recapitalization - - 5 (17%) -
Going Private - - 1 (3%) 155M (100%)
Consolidation - - 1 (3%) -
Secondary Buyout 1 (8%) - 1 (3%) -
Total 12 - 30 $155M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 8 (38%) 1.3B (89%)
Secondary Sale 8 (38%) 161M (11%)
Trade Sale 4 (19%) -
Merger 1 (5%) -
Total 21 $1.4B

Deal Values

buy # Total
$100M to $1B 1 $155M
TOTAL $155M
Largest Sheridan Healthcare, Inc.
$155M (1999-05-01)
sell # Total
$100M to $1B 3 $1.2B
< $100M 4 $262M
TOTAL $1.4B
Largest Vidara Therapeutics, Inc.
$660M (2014-03-19)

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
5 100%
Exited to
PE Firm(s)
47%
9 47%
Strategic(s)
53%
10 53%

Investor Summary

Size

Middle-Market

PE Assets

600M USD

Established

1983

Specialist/Generalist

Generalist

Leadership

Donald F. DeMuth

Co-founder & Partner

Keith W. Pennell

Managing Partner

Douglas H. Gilbert

Partner

Brian C. Tilley

Partner

Cheri E. Lieberman

CFO

 Subscribe to unlock this and 152,087
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 140K M&A Transactions
  • 148K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 41K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal